Intermittent preventive treatment of infants with mefloquine reduces risk of clinical malaria in areas of moderate malaria transmission and high resistance to sulphadoxine-pyrimethamine, but safety and tolerability issues need consideration.
| Main Author: | |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2010
|